BNY Mellon Fund Files Definitive Proxy in Fight Against Saba Capital, Urges Vote Against Board Declassification
DMB is trading near its 52-week low of $9.85 (12% above the low).
Summary
BNY Mellon Municipal Bond Infrastructure Fund filed its definitive proxy for the August 27 annual meeting, urging shareholders to reject Saba Capital's push to declassify the board and elect its own director. The board argues the activist's agenda threatens the fund's long-term income strategy.
Key Events · Corporate Governance and Compliance · DMB
-
Proxy Contest Escalates
The board filed a definitive proxy statement for the August 27, 2026 annual meeting, formally opposing Saba Capital's director nominee and a proposal to declassify the board.
-
Board Warns of Activist Threat
The board argues that declassification would allow an activist to gain control in a single meeting and force liquidity events like open-ending or liquidation, potentially reducing assets and increasing expenses for remaining shareholders.
-
Key Shareholder Stakes
Saba Capital holds 8.5% of common shares, while First Trust Portfolios holds 10.06%, making the vote highly contested.
-
Meeting and Voting Details
The virtual annual meeting is set for August 27, 2026, with a record date of June 25, 2026. The board urges shareholders to vote using the WHITE proxy card.
Analysis · DMB · Unknown
The definitive proxy statement escalates the proxy battle with activist Saba Capital. The board unanimously opposes Saba's nominee and the charter amendment to declassify the board, arguing it would enable short-term activists to seize control and force liquidity events harmful to long-term income investors. With Saba holding 8.5% and another large holder at 10.06%, the vote outcome is uncertain. The board warns that declassification could lead to open-ending or liquidation, potentially shrinking the fund and raising expenses for remaining shareholders.
At the time of this filing, DMB was trading at $11.03 on NYSE in the Unknown sector, with a market capitalization of approximately $203.2M. The 52-week trading range was $9.85 to $11.28. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.